CEO and President of $QLYS sells 2,699 shares in insider sale

The latest insider transaction data reveals that Sumedh S Thakar, as the CEO and President of $QLYS, recently sold 2,699 shares of the company on September 15, 2025, amounting to approximately $359,160. This sale represented about 1.3% of the shares of this particular stock class, leaving Thakar with ownership of 205,951 shares of $QLYS stock within this class.

Further examination of insider trading activity surrounding $QLYS in the past 6 months indicated a total of 75 transactions conducted by insiders. Among these transactions, 0 were purchases, while 75 were sales. Sumedh S Thakar led this trend by making 22 sales of 67,500 shares, generating an estimated $9,250,171. Other key figures engaging in this selling activity include John A. Zangardi with 3 sales of 8.250 shares amounting to $1,109,042, Joo Mi Kim with 21 sales of 6,143 shares totaling $814,699, and Jeffrey P Hank with 4 sales of 4,657 shares equating to $607,086. Additionally, Bruce K Posey conducted 17 sales of 3,180 shares for $420,440, Kristi Marie Rogers sold 1,700 shares for $228,997, Thomas Berquist made 4 sales of 1,168 shares amounting to $159,180, and Wendy Pfeiffer executed 3 sales of 600 shares, bringing in $81,590.

On the hedge fund front, a total of 226 institutional investors made increases to their holdings of $QLYS stock, while 240 decreased their positions in the stock in the most recent quarter. Notable movements within this realm include AQR Capital Management LLC, which added 323,324 shares (a 46.9% increase) to their portfolio in Q2 2025, totaling an estimated $46,193,299. Conversely, Van Berkman & Associates Inc. removed 273,259 shares entirely from their list of holdings in Q1 2025, amounting to an estimated $34,411,505. CDAM (UK) LTD reduced their shares by 34.6%, removing 211,598 shares in Q2 2025, equaling $30,231,006. Ameriprise Financial Inc. also significantly decreased their holdings, removing 80.9% of their shares in Q2 2025, totaling $26,124,493.

In terms of analyst ratings, several reports have been issued on $QLYS in recent months. The consensus among Wall Street analysts includes 2 firms issuing buy ratings on the stock and 2 firms issuing sell ratings. Noteworthy ratings include an “Outperform” rating by Wedbush on 08/06/2025 and a “Buy” rating by Canaccord Genuity on 05/07/2025. On the flip side, JP Morgan and Morgan Stanley both issued “Underweight” ratings on 04/28/2025 and 04/16/2025, respectively.

Multiple analysts have also put forth price targets for $QLYS in the last 6 months, with a median target of $150.0 based on 9 analysts’ forecasts. Recent price targets include Daniel Ives from Wedbush setting a target price of $155.0 on 08/06/2025, Roger Boyd from UBS targeting $150.0 on the same date, and Patrick Colville from Scotiabank also listing $150.0 on 08/06/2025. Moreover, Hamza Fodderwala from Morgan Stanley issued a lower target price of $97.0 on 08/06/2025, while Joseph Gallo from Jefferies, Rudy Kessinger from DA Davidson, and Matthew Hedberg from RBC Capital all set their target prices at $150.0, $135.0, and $140.0, respectively, during the same period.